Category Archives: Healthcare

BMO Capital Maintains Their Hold Rating on Bristol Myers (BMY)

In a report released yesterday, Alex Arfaei from BMO Capital maintained a Hold rating on Bristol Myers (BMY – Research Report). The company’s shares closed yesterday at $53.27. According to TipRanks.com, Arfaei is a 5-star analyst with an average return

Cantor Fitzgerald Thinks Evofem Biosciences Inc’s Stock is Going to Recover

Cantor Fitzgerald analyst William Tanner reiterated a Buy rating on Evofem Biosciences Inc (EVFM – Research Report) yesterday and set a price target of $9. The company’s shares closed yesterday at $3.37, close to its 52-week low of $1.79. Tanner

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Receives a Buy from Oppenheimer

In a report released yesterday, Esther Rajavelu from Oppenheimer maintained a Buy rating on Biohaven Pharmaceutical Holding Co Ltd (BHVN – Research Report), with a price target of $63. The company’s shares closed yesterday at $34.25. Rajavelu said: “BHVN reported

Oppenheimer Keeps a Buy Rating on Intec Pharma Ltd (NTEC)

Oppenheimer analyst Jay Olson maintained a Buy rating on Intec Pharma Ltd (NTEC – Research Report) yesterday and set a price target of $15. The company’s shares closed yesterday at $5.75. Olson commented: “NTEC reported a 3Q update with $9.5M

The EVP & GC of Ardelyx (NASDAQ: ARDX) is Selling Shares

Today, the EVP & GC of Ardelyx (ARDX – Research Report), Elizabeth Grammer, sold shares of ARDX for $18.57K. In addition to Elizabeth Grammer, 2 other ARDX executives reported Sell trades in the last month. See today’s analyst top recommended

The EVP Sales & Mkt of Prestige Brand Holdings (NYSE: PBH) is Buying Shares

Today, the EVP Sales & Mkt of Prestige Brand Holdings (PBH – Research Report), Timothy Connors, bought shares of PBH for $1.9M. Following this transaction Timothy Connors’ holding in the company was increased by 172.71% to a total of $2.32